<DOC>
	<DOCNO>NCT00753012</DOCNO>
	<brief_summary>The purpose research study learn effect medication call Vyvanse heart ( cardiovascular system ) . The U.S. Food Drug Administration ( FDA ) approve Vyvanse treatment Attention Deficit Hyperactivity Disorder ( ADHD ) . People ADHD trouble pay attention , organize , planning ; symptom cause problem work , socially home . Vyvanse ( also know Lisdexamfetamine ) stimulant class medication . There report serious cardiovascular effect child adult treat stimulant . While definite evidence event relate use stimulant , death raise question cardiovascular safety stimulant . The study involve in-depth cardiovascular test , namely echocardiograph ( ultrasound heart ) cardiopulmonary exercise test ( also call stress test ; subject exercise bicycle measure heart activity breathing monitor cardiologist ) . The investigator predict see change blood pressure heart rate show previous clinical study , in-depth cardiovascular test provide new insight cardiovascular impact stimulant .</brief_summary>
	<brief_title>Cardiovascular Study Lisdexamfetamine Healthy Hypertensive Attention Deficit Hyperactivity Disorder Adults</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>1 . Male female outpatient 1860 year age . 2 . A current DSMIVTR diagnosis ADHD , confirm Adult ADHD Clinical Diagnostic Scale ( ACDS ) Screening . 3 . In phase two ; Stage I primary hypertension ( SBP 140159 mm Hg/DBP 9099 mm Hg ) define Joint National Committee Prevention , Detection , Evaluation , Treatment High Blood Pressure ( Chobanian et al , 2003 ) . 4 . In phase two ; Treatment stable dos two FDA approve antihypertensive medication achieve stable blood pressure &lt; 135/85 . Acceptable class medication include diuretic , betablockers , angiotensinconvertingenzyme ( ACE ) inhibitor receptor blocker , aldosterone antagonist , calciumchannel blocker ( Rosendorff et al , 2007 ) . 1 . Pregnant nursing female . 2 . Clinically significant cardiovascular history , include angina , syncope , thrombosis , aneurysm , myocardial infarction , myocarditis , valvular disease , heart failure , arrhythmia . Hypertension exclusionary phase one subject . 3 . In phase two ; hypertension exclusionary , however blood pressure antihypertensive treatment â‰¥135/85 baseline exclusionary . 4 . Clinically significant unstable medical condition include pulmonary ( asthma , edema , thrombosis ) , renal , hepatic , metabolic ( thyroid ) neurological disorder , base upon medical history . 5 . Orthopedic impairment BMI significantly impact restricts exercise performance testing , per clinician judgment . 6 . Any clinically unstable psychiatric condition include suicidality , homicidality , bipolar disorder , psychosis . 7 . Current ( within 3 month ) DSMIVTR criterion current abuse dependence psychoactive substance nicotine , include alcohol , prescription medicine and/or street drug . In addition , subject clinically significant history dependence alcohol , prescription medication `` street drug '' exclude , history place subject heighten risk , and/or may associate cardiovascular sequela , base clinician judgment . 8 . Ongoing treatment psychotropic medication , include anxiolytic , antidepressant , mood stabilizer . 9 . Use Monoamine Oxidase Inhibitors ( MAOIs ) include linezolid within two week prior start study medication . 10 . Mental retardation ( IQ &lt; 75 ) . 11 . History intolerance allergy LDX . 12 . Diagnosis glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>cardiovascular testing</keyword>
	<keyword>home blood pressure monitoring</keyword>
	<keyword>office home blood pressure monitoring</keyword>
	<keyword>cardiopulmonary exercise testing</keyword>
	<keyword>transthoracic echocardiography</keyword>
	<keyword>Lisdexamfetamine</keyword>
	<keyword>Vyvanse</keyword>
	<keyword>normotensive hypertensive adult ADHD</keyword>
	<keyword>ADHD medication .</keyword>
</DOC>